Search Results - "Khachatryan, Derenik S"
-
1
New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors
Published in Molecules (Basel, Switzerland) (15-10-2019)“…Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a promising therapeutic target in cancer therapy. Combination chemotherapy using Tdp1 inhibitors as a component can…”
Get full text
Journal Article -
2
Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging
Published in Pharmaceutics (01-12-2022)“…Magnetic nanosystems (MNSs) consisting of magnetic iron oxide nanoparticles (IONPs) coated by human serum albumin (HSA), commonly used as a component of hybrid…”
Get full text
Journal Article -
3
Biologically active quinazoline-based hydroxamic acids
Published in Medicinal chemistry research (01-05-2020)“…Molecular hybridization has become a new promising way to treat multifactorial diseases with a single compound that acts on multiple targets. The combination…”
Get full text
Journal Article -
4
Labeling and receptor affinity of an ultra‐short somatostatin analogue Thz‐Phe‐D‐Trp‐Lys‐Thr‐DOTA
Published in Journal of peptide science (01-12-2021)“…Somatostatin analogues play an important role in the therapy of neuroendocrine tumors by binding to somatostatin receptors on the surface of cancer cells. In…”
Get full text
Journal Article -
5
Nonmetallic Wurtz coupling reaction of perfluorohexyl iodide
Published in Tetrahedron letters (11-07-2018)“…[Display omitted] •A new pathway of dimerization of perfluoroalkyl halides to perfluoroalkanes was found.•Perfluoroalkyl halides under the action of…”
Get full text
Journal Article -
6
Synthesis of new quinazoline-containing hydroxamic acids as potential HDAC/VEGFR inhibitors. Unusual rearrangements with pyrrolidone ring opening and dehydration of 3-N-hydroxyquinazoline fragment containing tetracycles
Published in Tetrahedron letters (19-12-2019)“…[Display omitted] Synthesis pathways were developed and new hydroxamic acids were obtained as potential inhibitors of HDAC/VEGFR2, including tetracycles…”
Get full text
Journal Article -
7
[161Tb]Tb-Thz-Phe-D-Trp-Lys-Thr-DOTA: A potential radiopharmaceutical for the treatment of neuroendocrine tumors
Published in Mendeleev communications (01-07-2023)“…[Display omitted] Thz-Phe-D-Trp-Lys-Thr-DOTA, a conjugate of the DOTA chelator and the Thz-Phe-D-Trp-Lys-Thr pentapeptide, was labeled with 152Eu and 161Tb…”
Get full text
Journal Article